协和医学杂志

2021, v.12(01) 5-8

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Past Issue) | 高级检索(Advanced Search)

新型冠状病毒肺炎的药物治疗:时机决定预后
Treatment of Coronavirus Disease 2019:Timing Determines Prognosis

曹玮;李太生;
CAO Wei;LI Tai-sheng;Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College;

摘要(Abstract):

新型冠状病毒肺炎全球疫情仍在不断蔓延。对这一新发疾病的应对离不开对其临床特点及病理生理机制的研究。尽管目前临床治疗选择仍十分有限,但现有经验已经表明,需根据患者所处的病程阶段和自身免疫特点选择相应的临床治疗策略。本文回顾新型冠状病毒的临床特点及不同类型药物的现有证据,结合一线抗疫经验,总结当前新型冠状病毒肺炎的临床关键节点和相应治疗策略。
The global epidemic of coronavirus disease 2019(COVID-19) is still growing. The response to this emerging disease should be considered with the context of its clinical characteristics and pathophysiological mechanisms. Although available therapeutic options are still very limited, current experience has suggested that the choice of clinical strategies should be based upon the disease stage and immune functions of the patients. The present article reviews the clinical characteristics of COVID-19 and current evidence of various treatment approaches. Combined with first-line experience, we summarize the current clinical strategies for COVID-19 management based on disease progress and staging.

关键词(KeyWords): 新型冠状病毒;肺炎;免疫炎症;凝血异常;治疗
SARS-CoV-2;pneumonia;immune inflammation;coagulopathy;treatment

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 曹玮;李太生;
CAO Wei;LI Tai-sheng;Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College;

Email:

DOI:

参考文献(References):

扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享